Position in ABSI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,895,497
+$1,711,720 QoQ
Shares Held
163,546
+167.0% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 195 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ABSI ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ABSI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,895,497 | 163,546 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $183,777 | 61,259 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $543,182 | 155,640 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $275,490 | 90,622 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $171,883 | 66,881 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $121,827 | 48,537 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $115,350 | 44,027 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $118,339 | 30,979 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $96,310 | 31,270 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,805 | 494 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $48,867 | 11,635 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $218,563 | 165,579 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $243,061 | 159,909 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $278,943 | 159,396 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $284,852 | 135,644 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $576,034 | 184,037 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,123 | 2,447 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $296,322 | 35,151 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $136,529 | 16,650 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,840 | 1,964 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||